Disclaimer :

The Competition DG makes the information provided by the notifying parties in section 1.2 of Form CO available to the public in order to increase transparency. This information has been prepared by the notifying parties under their sole responsibility, and its content in no way prejudges the view the Commission may take of the planned operation. Nor can the Commission be held responsible for any incorrect or misleading information contained therein.

SECTION 1.2

Description of the concentration

The contemplated transaction relates to the acquisition of indirect sole control within the meaning of Article 3(1)(b) of the European Union Merger Regulation (the “EUMR”) of Dentix Health Corporation, S.L.U. (an entity incorporated in Spain) by KKR & Co. Inc. (incorporated in the U.S.) from its sole equity holder, Ángel Lorenzo Muriel.

Dentix Health Corporation, S.L.U. (“Dentix”) is a provider of dental care services, through a network of more than 370 fully owned and operated clinics across Spain, Italy, Portugal, Colombia, Chile, Mexico and the UK. KKR & Co. Inc. (“KKR”) is a global investment firm, which offers a broad range of alternative asset funds and other investment products to investors and provides capital markets solutions for the firm, its portfolio companies and other clients.

The Transaction will be implemented by way of a debt-to-equity swap. Following completion of the Transaction, KKR will indirectly hold 95% of the voting equity of Dentix, the balance of which will remain with Ángel Lorenzo Muriel.

Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË

Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.